Short seller Scorpion Capital disclosed a short position in TransMedics Group Inc (NASDAQ:TMDX) accusing the organ transplant ...

Eli Lilly (NYSE:LLY) is in advanced discussions to purchase cancer-focused biotech Scorpion Therapeutics for as much as $2.5 ...

Shares of TransMedics Group ( TMDX -12.34%) were tanking 14.3% lower as of 10:46 a.m. ET on Friday. The big sell-off came after activist short seller Scorpion Capital released a scathing report about ...

Scorpion’s drug candidate inhibits a mutation that is a major driver of breast, gynaecological and head and neck cancers ...

In a Patreon post by industry insider Daniel Richtman (via ComicBook ), he shared a little insight into the now scrapped ...

According to industry insider Daniel Richtman, Marvel's team is still rewriting the script for the movie after Kevin Fiege ...

STX-478 is under clinical development by Scorpion Therapeutics and currently in Phase II for Endometrial Cancer.

TrafFix Devices, a leading manufacturer and supplier of traffic control devices and crash attenuation products, highlights the Scorpion II Blocker, a cutting-edge truck-mounted attenuator (TMA ...